arginase 1
Selected indexed studies
- Arginase-1 deficiency. (J Mol Med (Berl), 2015) [PMID:26467175]
- Arginase 1 is a key driver of immune suppression in pancreatic cancer. (Elife, 2023) [PMID:36727849]
- Erythrocyte-derived extracellular vesicles induce endothelial dysfunction through arginase-1 and oxidative stress in type 2 diabetes. (J Clin Invest, 2025) [PMID:40111409]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Arginase-1 deficiency. (2015) pubmed
- Arginase 1 is a key driver of immune suppression in pancreatic cancer. (2023) pubmed
- Erythrocyte-derived extracellular vesicles induce endothelial dysfunction through arginase-1 and oxidative stress in type 2 diabetes. (2025) pubmed
- Arginase-1-specific T cells target and modulate tumor-associated macrophages. (2025) pubmed
- Arginase 1 deficiency: a treatable form of spastic paraplegia. (2025) pubmed
- More than a Marker: Arginase-1 in Kidney Repair. (2022) pubmed
- Loss of CD4(+) T cell-intrinsic arginase 1 accelerates Th1 response kinetics and reduces lung pathology during influenza infection. (2023) pubmed
- Human arginase 1, a Jack of all trades? (2022) pubmed
- Ginseng-derived nanoparticles reprogram macrophages to regulate arginase-1 release for ameliorating T cell exhaustion in tumor microenvironment. (2023) pubmed
- Arginase-1 Is Required for Macrophage-Mediated Renal Tubule Regeneration. (2022) pubmed